FDA panel votes against panobinostat as add-on therapy for multiple myeloma

Read the full story on MD Consult: FDA panel votes against panobinostat as add-on therapy for multiple myeloma
Source: MD Consult: News: Top Stories - Category: Journals (General) Source Type: news